Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Xilinx Q4 Profit Down - Quick Facts

RELATED NEWS
Trade XLNX now with 

Xilinx Inc. (XLNX: Quote) reported that its fourth quarter net income declined to $134.1 million, or $0.49 per share, from $160.1 million or $0.59 per share in the same quarter last year.

Net revenue was $558.97 million, down from $587.85 million in the year ago quarter.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.41 per share on revenues of $531.59 million for the quarter. Analysts' estimates typically exclude special items.

For the first-quarter, Sales are expected to be up 1% to up 5% sequentially. Gross margin is expected to be approximately 65% - 66%. Analysts expect the company to report revenues of $552.64 million for the first-quarter.

Click here to receive FREE breaking news email alerts for Xilinx Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Home improvement and building products company Masco Corp. said Monday after the markets closed that its second quarter profit jumped 78% from last year, as revenue increased and margins improved amid strong performance of its Plumbing Products, Installation and Other Services and Decorative Architectural Products segments. American Financial Group Inc. (AFG) Monday reported second-quarter net earnings of $106 million or $1.15 per share, compared to $110 million or $1.20 per share last year. Core net operating earnings were $99 million or $1.07 per share, compared to $87 million or $0.96 per share last year. Total... Stocks showed a significant recovery over the course of the trading day on Monday after coming under pressure in early trading. The markets eventually ended the session roughly flat following the mixed performance that was seen last week.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.